Name：Jing Zhang

Position：Associate Professor

E-mail：zhangjing1985zj@163.com

Personal Statement:

Academic and Professional Background

Dr. Jing Zhang obtained her Ph.D. from China Medical University in 2018. She subsequently served as a visiting scholar at the University of North Carolina at Chapel Hill. In 2012, Dr. Zhang was appointed Associate Professor at the National Health Commission Key Laboratory of AIDS Immunology, China Medical University. She currently holds the position of Associate Professor in the School of Public Health at Shenzhen University, a role she assumed in 2022. Her distinguished contributions to public health have earned her recognition as a Shenzhen Peacock High-Level Talent.

Research Expertise and Achievements

Dr. Zhang has dedicated her career to advancing epidemiological research and evidence-based clinical investigations into major disease burdens. Her work employs longitudinal cohort studies, randomized controlled trials, and predictive modeling to elucidate the distribution, determinants, and transmission dynamics of both infectious and chronic diseases. She has published extensively in high-impact peer-reviewed journals, including The BMJ, The Lancet Child & Adolescent Health, The Lancet HIV, and Cell Reports Medicine, etc. where she has held roles as first author or co-corresponding author.

Research Interests:

HIV/AIDS and other sexually transmitted infections prevention

Diabetes and comorbidity prevention

Risk prediction models

Research Projects:

1. National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2012ZX10001006-001-010): 01/01/2018-12/31/2019 ￥490,000

2. NSFC (China) Project (82304201):  01/01/2024 to 12/31/2026  ￥300,000

3. GuangDong Basic and Applied Basic Research Foundation (2024A1515012123):  01/01/2024 to 12/31/2026 ￥150,000

4. Shenzhen Peacock Team:  01/01/2023 to 12/31/2026 ￥2,000,000

Selected Peer-reviewed Publications:

1. Increasing prevalence of type 1 diabetes in older age may be a good sign. BMJ. 2024 Jun 14:385:q1322. doi: 10.1136/bmj.q1322.（IF=106.7）

2. Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population-based study. BMJ. 2024 Jun 12:385: e078432. doi: 10.1136/bmj-2023-078432. （IF=106.7）

3. Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10–24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. Lancet Child & Adolescent Health. 2022. (IF=37.7)

4. Burden of noncommunicable diseases among children and adolescents aged 10-24 years in China, 1990-2019: A population-based study. Cell Reports Medicine. 2023 Dec 19;4(12):101331. doi: 10.1016/j.xcrm.2023.101331.(IF=14.3)

5. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis Lancet HIV. 2022 Apr;9(4):e254-e268. doi: 10.1016/S2352-3018(22)00030-3.（IF=12.8）